Published by Josh White on 29th March 2021
(Sharecast News) - Diagnostic antibody developer Bioventix reported a 1.3% improvement in revenue in its first half on Monday, to £5.2m.
URL: http://www.digitallook.com/dl/news/story/31738435/...